自身免疫性GFAP星形细胞病表现为伴软脑膜强化的脑脊髓炎
本文报告一名50岁香港男性在病毒感染后出现进行性尿潴留、构音障碍、复视和步态共济失调,入院第6天增强MRI显示弥漫性基底及脊髓软脑膜强化,脑脊液嗜酸性粒细胞增多曾促使经验性抗结核治疗。停用地塞米松后临床与影像恶化,脑脊液GFAP-IgG免疫荧光试验阳性(1:128)确诊自身免疫性GFAP星形细胞病,经大剂量皮质类固醇、静脉免疫球蛋白和利妥昔单抗诱导治疗后临床与影像缓解。
要点
- 软脑膜强化是自身免疫性GFAP星形细胞病可能的表现之一,应纳入鉴别诊断。
- 脑脊液GFAP-IgG检测是确诊该病的关键,应在鉴别诊断中尽早送检。
- 该病对皮质类固醇敏感,停药可致临床与影像恶化,需规范诱导与维持治疗。
核心结论
- 自身免疫性GFAP星形细胞病可表现为软脑膜强化和T2/FLAIR高信号,脑脊液GFAP-IgG检测可确诊,属对皮质类固醇敏感的疾病。
研究设计与样本
- 个案报告:一名50岁来自香港的男性,病毒感染后出现进行性尿潴留、构音障碍、复视和步态共济失调。
主要发现
- 初始平扫脑MRI阴性,入院第6天增强MRI显示弥漫性基底及脊髓软脑膜强化。
- 脑脊液嗜酸性粒细胞增多合并流行病学危险因素,促使经验性抗结核脑膜炎治疗(含地塞米松)。
- 停用地塞米松后出现临床与影像恶化,脑脊液GFAP-IgG免疫荧光试验阳性(1:128)确诊。
- 大剂量皮质类固醇、静脉免疫球蛋白和利妥昔单抗诱导治疗后达临床与影像缓解。
关键数值与推荐
- 脑脊液GFAP-IgG免疫荧光试验阳性(1:128)支持自身免疫性GFAP星形细胞病诊断。
- 特征性影像为血管周围放射状强化,但也可出现软脑膜强化和T2/FLAIR高信号。
临床怎么用
- 对软脑膜强化患者应将自身免疫性GFAP星形细胞病纳入鉴别,并尽早送检脑脊液GFAP-IgG。
- 确诊后采用大剂量皮质类固醇等免疫治疗诱导缓解,避免无计划停用皮质类固醇。
局限性
- 本文为单个病例报告,诊疗经验与结论的外推需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is an uncommon diagnosis in the differential for leptomeningeal enhancement. This case highlights the presentation, imaging features, and investigations important for diagnosis of GFAP astrocytopathy to ensure timely treatment of this corticosteroid-responsive disease. A 50-year-old man from Hong Kong presented with 10 days of progressive urinary retention, dysarthria, diplopia, and gait ataxia after a viral illness. Initial nonenhanced MRI brain was negative. After he developed encephalopathy, repeat MRI with gadolinium on admission day 6 revealed diffuse basal and spinal cord leptomeningeal enhancement. This imaging pattern, in combination with CSF eosinophilia and epidemiologic risk factors, precipitated empiric treatment for tuberculosis meningitis (including dexamethasone). Extensive investigations for an alternate infectious, autoimmune, or malignant diagnosis were negative. Dexamethasone cessation after a gastrointestinal bleed led to clinical and radiologic deterioration. This prompted further CSF and serum testing, which showed positive CSF GFAP-IgG immunofluorescence assay (IFA) (1:128) solidifying the diagnosis of autoimmune GFAP astrocytopathy. Induction with high-dose corticosteroids, intravenous immunoglobulins, and rituximab produced clinical and radiologic remission. Autoimmune GFAP astrocytopathy is an autoimmune disorder with a characteristic perivascular radial enhancement imaging pattern. However, a variety of other clinical and radiologic presentations may be seen, including leptomeningeal enhancement and T2/FLAIR hyperintensities. Diagnosis is confirmed with CSF GFAP-IgG testing. We provide a differential diagnosis for leptomeningeal enhancement and highlight clinical pearls for the diagnosis and management of autoimmune GFAP astrocytopathy.
引用
- Vu AP, Kapadia RK, Roberts JI, et al. Pearls & Oy-sters: Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting as Encephalomyelitis With Leptomeningeal Enhancement. Neurology. 2025. PMID: 40315395. doi:10.1212/WNL.0000000000213662
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。